Form D — Accretion Therapeutics, Inc.
0002109293-26-000001 · filed Feb 17, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $1,000,000
- Reported amount sold
- $750,000
- Minimum investment
- $750,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Accretion Therapeutics, Inc.
- CIK
- 2109293
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 416 OLD MILL CIR
LINCOLNSHIRE, IL 60069 - Phone
- 8473233236
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Holecek · Executive OfficerLincolnshire, IL Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗